Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gendicine in Advanced Malignant Thyroid Tumors
NCT00902122Phase 4Unknown
- Sponsor
- Shenzhen SiBiono GeneTech
- Start
- May 2009
- Primary completion
- Aug 2012
- Modality
- Gene Editing, Gene Silencing, Viral Vectors
- Countries
- 1
01
Overview
A Phase 4 trial of rAdp53 in thyroid cancer, sponsored by Shenzhen SiBiono GeneTech. Status: unknown.
02
Drugs
rAdp53
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT00902122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902122.